Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fluorescence-activated cell sorting and phenotypic characterization of human fibro-adipogenic progenitors. | STAR Protoc | 2023 | 36640368 | PubTator, text mining | PubMed |
| Treatments for early-stage Dupuytren's disease: an evidence-based approach. | J Hand Surg Eur Vol | 2023 | 36638105 | PubTator, text mining | PubMed |
| Surface Morphology and Subsurface Microstructure Evolution When Form Grinding 20Cr2Ni4A Alloys. | Materials (Basel) | 2023 | 36614765 | PubTator, text mining | PubMed |
| Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products. | Cancers (Basel) | 2023 | 36612314 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer. | Cancers (Basel) | 2023 | 36612299 | PubTator, text mining | PubMed |
| Suicide and other causes of death among Chernobyl cleanup workers from Estonia, 1986 - 2020: an update. | Eur J Epidemiol | 2023 | 36609895 | PubTator, text mining | PubMed |
| Clinicopathological Significances and Prognostic Value of PPFIA4 in Colorectal Cancer. | J Cancer | 2023 | 36605492 | PubTator, text mining | PubMed |
| Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. | Mater Today Bio | 2023 | 36593913 | PubTator, text mining | PubMed |
| A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models. | Nanotheranostics | 2023 | 36593796 | PubTator, text mining | PubMed |
| ADAM10-a "multitasker" in sepsis: focus on its posttranslational target. | Inflamm Res | 2023 | 36565333 | PubTator, text mining | PubMed |
| Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine). | J Control Release | 2023 | 36549393 | PubTator, text mining | PubMed |
| The tetraspanin CD53 protects stressed hematopoietic stem cells via promotion of DREAM complex-mediated quiescence. | Blood | 2023 | 36542833 | PubTator, text mining | PubMed |
| Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes. | J Endocrinol Invest | 2023 | 36528847 | PubTator, text mining | PubMed |
| The Effect of Extracellular Vesicles on Thrombosis. | J Cardiovasc Transl Res | 2023 | 36441349 | PubTator, text mining | PubMed |
| The Role of Host Cell Glycans on Virus Infectivity: The SARS-CoV-2 Case. | Adv Sci (Weinh) | 2023 | 36417571 | PubTator, text mining | PubMed |
| An integrated interval-valued intuitionistic fuzzy technique for resumption risk assessment amid COVID-19 prevention. | Inf Sci (N Y) | 2023 | 36406041 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation. | Stem Cell Reports | 2023 | 36400027 | PubTator, text mining | PubMed |
| The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML. | Blood Adv | 2023 | 36383712 | PubTator, text mining | PubMed |
| Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy. | Leukemia | 2023 | 36380143 | PubTator, text mining | PubMed |
Impact of coexisting diabetes on survival and risk of developing second primary cancer in diabetes patients receiving drug therapy: A multicenter retrospective cohort study of patients with cancer in Japan. | J Diabetes Investig | 2023 | 36345271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=26